Better genetic medicines, built with AI.

Kerna Labs is unlocking the full potential of mRNA as the universal toolkit for genetic medicine.

Despite its potential, mRNA is held back by key bottlenecks in payload design and delivery.

Kerna Labs solves these key limitations with cutting-edge payload design.

Unlocking New Potential in RNA-Based Therapies

We leverage advanced computational techniques and high-throughput biology to fundamentally change the way we do drug discovery and development.

mRNA Therapeutics
That Have

Expression Curve Tuning

Customizable expression profiles for diverse therapeutic applications.

Cell-Type Specific Expression

Precision-targeted delivery for cell-specific therapeutic effects.

Enhanced Half-life

Prolonged efficacy window through optimized mRNA stability.

Kerna Labs is building foundation models to programmatically develop better mRNA therapeutics.

Meet Our Team

Built and backed by the leading minds in machine learning and mRNA.

Amit Deshwar, PhD

Co-founder & CTO

Melissa J. Moore, PhD

Co-founder

Julia Peng

Co-founder & CEO

Michael Swift, PhD

Founding Scientist

Aryan Misra

Machine Learning Engineer

Oliver Chang, PhD

Platform Scientist

Our Mission

We are revolutionizing genetic medicine

We are paving the way for a new generation of therapies by leveraging AI and high-throughput biology to decode RNA biology.

Get Connected

Learn more about how we're enabling our partners in their mRNA pipeline development.